Drug industry antitrust act. Hearings before the Subcommittee on Antitrust and Monopoly of the Committee on the Judiciary, United States Senate, Eighty-seventh Congress, first [-second] session, pursuant to S. Res. 52 on S. 1552, a bill to amend and supplement the antitrust laws, with respect to the manufacture and distribution of drugs, and for other purposes

Author / Creator

United States. Congress. Senate. Committee on the Judiciary

Available as

Physical